A Generalized Continual Reassessment Method for Two-Agent Phase I Trials

Statistics in Biopharmaceutical Research

Volumn 5, Issue 2, 2013, Pages 105-115

  Braun, Thomas M ^a   Jia, Nan ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Bayesian methods; Clinical trials; Dose escalation; Dose finding; Proportional odds model

Indexed keywords

ALGORITHM; ARTICLE; BAYES THEOREM; COMPARATIVE STUDY; COMPUTER SIMULATION; CONTINUAL REASSESSMENT METHOD; CORRELATION ANALYSIS; DOSE CALCULATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; PHASE 1 CLINICAL TRIAL (TOPIC); PROBABILITY; SAMPLE SIZE; STATISTICAL ANALYSIS; STATISTICAL DISTRIBUTION; STATISTICAL PARAMETERS; STATISTICAL SIGNIFICANCE;

EID: 84880991035     PISSN: None     EISSN: 19466315     Source Type: Journal    
DOI: 10.1080/19466315.2013.767213     Document Type: Article

References (16)

1. Braun, T. and Wang, S. 2010. "A Hierarchical Bayesian Design for Phase I Trials of Novel Combinations of Cancer Therapeutic Agents,". Biometrics, 66: 805 - 812.
2. Conaway, M., Dunbar, S. and Peddada, S. 2004. "Designs for Single or Multiple-Agent Phase I Trials,". Biometrics, 60: 661 - 669.
3. Faries, D. 1994. "Practical Modifications of the Continual Reassessment Method for Phase I Cancer Clinical Trials,". Journal of Biopharmaceutical Statistics, 4: 147 - 164.
4. Goodman, S., Zahurak, M. and Piantadosi, S. 1995. "Some Practical Improvements in the Continual Reassessment Method for Phase I Studies,". Statistics in Medicine, 14: 1149 - 1161.
5. Lee, S. M. and Cheung, Y. K. 2011. "Calibration of Prior Variance in the Bayesian Continual Reassessment Method,". Statistics in Medicine, 30: 2081 - 2089.
6. O'Quigley, J. and Paoletti, X. 2003. "Continual Reassessment Method for Ordered Groups,". Biometrics, 59: 430 - 440.
7. O'Quigley, J., Pepe, M. and Fisher, L. 1990. "Continual Reassessment Method: A Practical Design for Phase I Clinical Trials in Cancer,". Biometrics, 46: 33 - 48.
8. O'Quigley, J. and Shen, L. 1996. "Continual Reassessment Method: A Likelihood Approach,". Biometrics, 52: 673 - 684.
9. Rowinsky, E., Kaufmann, S., Baker, S., Grochow, L., Chen, T., Peereboom, D., Bowling, M., Sartorius, S., Ettinger, D., Forastiere, A. and Donehower, R. 1996. "Sequences of Topotecan and Cisplatin: Phase I, Pharmacologic, and In Vitro Studies to Examine Sequence Dependence,". Journal of Clinical Oncology, 14: 3074 - 3084.
10. Thall, P., Millikan, R. E., Mueller, P. and Lee, S.-J. 2003. "Dose-Finding With Two Agents in Phase I Oncology Trials,". Biometrics, 59: 487 - 496.
11. Wages, N., Conaway, M. and O'Quigley, J. 2011a. "Continual Reassessment Method for Partial Ordering,". Biometrics, 67: 1555 - 1563.
12. Wages, N., Conaway, M. and O'Quigley, J. 2011b. "Dose-Finding Design for Multi-Drug Combinations,". Clinical Trials, 8: 380 - 389.
13. Wang, K. and Ivanova, A. 2005. "Two-Dimensional Dose Finding in Discrete Dose Space,". Biometrics, 61: 217 - 222.
14. Yin, G. and Yuan, Y. 2009. "Bayesian Dose Finding in Oncology for Drug Combinations by Copula Regression,". Journal of the Royal Statistical Society, 58: 211 - 224.
15. Yuan, Y. and Yin, G. 2008. "Sequential Continual Reassessment Method for Two-Dimensional Dose Finding,". Statistics in Medicine, 27: 5664 - 5678.
16. Yuan, Y. and Yin, G. 2009. "A Latent Contingency Table Approach to Dose Finding for Combinations of Two Agents,". Biometrics, 65: 866 - 875.